Fibromyalgia Trial, Recruiting NCT06338514 Sponsor: Kutahya Health Sciences University Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT06338514
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with Dorsal Myofascial Pain Syndrome related to trigger points in the rhomboid and trapezius muscles (muscles in the upper back and shoulders).
  • People whose shoulder pain rates 6 or higher on a 10-point pain scale.
  • People who are able to read and write.

Who may not be able to join:

  • People who have had surgery on their spine at any point in the past.
  • People who have skin damage, muscle wasting, or scarring in the area around their back.
  • People who have received physiotherapy targeting the back or lower back within the last 6 months.
  • People who have had an interventional procedure (such as an injection or similar treatment) for back or lower back pain within the last 3 months.
  • People who have used steroid medications within the last month.
  • People who have certain conditions such as epilepsy, pregnancy, or a phobia of injections, among others (confirm with trial site for the full list).
  • People who are unable to avoid using steroid or anti-inflammatory medications (such as ibuprofen or similar drugs) during the treatment period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hasan H Gökpınar, Ass. Prof., Kutahya Health Sciences University

Phone: 05052842222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kutahya Health Sciences University
Registry
ClinicalTrials.gov
Start date
25 April 2024
Est. completion
10 October 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Visual Analog Scale; Patient-Specific Functional Scale; Pressure Pain Threshold Measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov